Vericel legal chief Sean C. Flynn sells 15,000 shares
The options called for 25% vesting on November 4, 2020, then equal quarterly installments over three years, contingent on continued service.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Vericel Corp's Chief Legal Officer Sean C. Flynn exercised options to acquire 15,000 shares on November 5, 2026, at an exercise price of $16.25 per share, then sold 15,000 common shares at $51.92 per share that day. The sale was an automatic sale under a Rule 10b5-1 trading plan adopted December 2, 2025. Following the exercise, his reported options covered 40,000 shares and had an expiration date of November 4, 2029.
Insider Trade Summary 10b5-1
Exercise and Sale: 15,000 shares ($535K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Flynn Sean C.
Role
Chief Legal Officer
Sold
15,000 shs ($779K)
Approx. gross sale proceeds
$779K
Approx. exercise cost
$244K
Approx. pre-tax spread
$535K
Share of Position Sold
88.3%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F3 | 15,000 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 15,000 | $16.25 | $244K |
| Sale | Common Stock F2, F1 | 15,000 | $51.92 | $779K |
Holdings After Transaction:
Stock Option (Right to Buy) — 40,000 contracts (Direct);
Common Stock — 1,990 shares (Direct)
Holdings Before and After:
Stock Option (Right to Buy), 25,000 to 40,000 contracts (Direct);
Common Stock, 1,990 to 1,990 shares (Direct)
Other Insiders: 2 other insiders reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (3)
- F1. These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- F2. The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
- F3. These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.
Key Figures
Options exercised: 15,000 shares
Exercise price: $16.25 per share
Common shares sold: 15,000 shares
+4 more
7 metrics
Options exercised
15,000 shares
November 5, 2026
Exercise price
$16.25 per share
Options exercised November 5, 2026
Common shares sold
15,000 shares
November 5, 2026
Sale price
$51.92 per share
November 5, 2026
Options following exercise
40,000 shares
Reported following the November 5, 2026 exercise
Option expiration
November 4, 2029
Options reported in the transaction
Rule 10b5-1 plan adoption
December 2, 2025
Plan for the reported sale
Key Terms
Rule 10b5-1 trading plan, 2015 Employee Stock Purchase Plan, Rule 16b-3(d), Rule 16b-3(c)
4 terms
Rule 10b5-1 trading plan regulatory
"automatic sale pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
2015 Employee Stock Purchase Plan financial
"Issuer's 2015 Employee Stock Purchase Plan"
Rule 16b-3(d) regulatory
"exempt under both Rule 16b-3(d) and Rule 16b-3(c)"
Rule 16b-3(d) is a narrow SEC safe-harbor that shields company insiders (officers, directors and large shareholders) from liability for short‑swing profits when their buys or sells of company stock are made under a pre-established, written plan or contract that removes the insider’s ability to time trades. For investors, this matters because it permits predictable, automated insider transactions — like scheduled sales for diversification or payroll withholding — without triggering forced disgorgement, so such planned trades are treated differently from opportunistic insider trading.
Rule 16b-3(c) regulatory
"exempt under both Rule 16b-3(d) and Rule 16b-3(c)"
An SEC rule that lets corporate insiders avoid automatic "short‑swing" profit recovery when they buy or sell their company’s stock under a pre‑approved, written plan that meets specific conditions. For investors, it matters because it clarifies when insider trades are treated as routine, reducing legal uncertainty and helping distinguish trades made for ordinary compensation or pre‑planned reasons from those that might signal opportunistic or timely insider advantage.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What vesting schedule applied to Sean C. Flynn's VCEL options?
The options represented the right to purchase 150,000 shares and became exercisable November 4, 2020, the first anniversary of the grant date. 25% vested then, with the remaining 75% vesting in equal quarterly installments over three years, contingent on continued service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
